Core Insights - Huajian Medical (01931.HK) has officially launched a strategy for a "Global Enhanced Ethereum (ETH) Treasury" with a focus on establishing a reserve treasury for ETH and aims to become the largest publicly listed entity holding Ethereum [1] Group 1: Strategic Framework - The strategy is supported by two main frameworks: the establishment of an ETH reserve treasury with a dollar-cost averaging approach to continuously increase ETH holdings, and the creation of an ETH value generation engine (ivd.xyz exchange) [1] - The closed-loop model involves "acquisition of innovative drug IP - RWA tokenization - ecological revenue conversion to ETH - treasury reserve enhancement," aimed at achieving asset appreciation and a virtuous cycle [1] Group 2: Downside Protection Mechanism - The strategy features a multi-layered "downside protection mechanism" designed to safeguard the interests of shareholders, RWA holders, and potential investors amid increased market volatility [1] - This mechanism employs diversified risk hedging methods to ensure the safety of investments [1] Group 3: Investment Approach - The innovative design allows Web2 investors to capture financial benefits from Web3 without fear of market fluctuations, effectively bridging traditional financial institutions and digital assets [1] - The strategy transitions ETH assets from "passive holding" to "active income generation, reinvestment, and expansion" [1]